Citius Pharmaceuticals, Inc. Amortization of Debt Discount (Premium)
Citius Pharmaceuticals, Inc. (CTXR) reported Amortization of Debt Discount (Premium) of $833.33 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2018-12-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2019-12-16
- Citius Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2014-06-30 was $3.50K.
- Citius Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2014-03-31 was $10.50K.
- Citius Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2013-12-31 was $10.50K.
- Citius Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2018 was $833.33K, a 0.00% change from fiscal 2017.
- Citius Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2017 was $833.33K.
- Citius Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2013 was $28.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2018-09-30 | $833.33K 10-K · filed 2018-12-11 | |||
| 2017-09-30 | $833.33K 10-K · filed 2019-12-16 | |||
| 2014-09-30 | $14.00K 10-K · filed 2015-12-14 | |||
| 2014-06-30 | $3.50K 10-Q · filed 2015-08-13 | $14.00K derived: sum of 2 quarters · filed 2015-08-13 | $24.50K 10-Q · filed 2015-08-13 | |
| 2014-03-31 | $10.50K 10-Q · filed 2015-05-13 | $21.00K 10-Q · filed 2015-05-13 | ||
| 2013-12-31 | $10.50K 10-Q · filed 2015-02-17 | $28.00K 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |